Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

B-cell memory in malaria: Myths and realities.

Pérez-Mazliah D, Ndungu FM, Aye R, Langhorne J.

Immunol Rev. 2020 Jan;293(1):57-69. doi: 10.1111/imr.12822. Epub 2019 Nov 16. Review.

2.

The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.

Muriuki JM, Mentzer AJ, Band G, Gilchrist JJ, Carstensen T, Lule SA, Goheen MM, Joof F, Kimita W, Mogire R, Cutland CL, Diarra A, Rautanen A, Pomilla C, Gurdasani D, Rockett K, Mturi N, Ndungu FM, Scott JAG, Sirima SB, Morovat A, Prentice AM, Madhi SA, Webb EL, Elliott AM, Bejon P, Sandhu MS, Hill AVS, Kwiatkowski DP, Williams TN, Cerami C, Atkinson SH.

Sci Adv. 2019 Sep 4;5(9):eaaw0109. doi: 10.1126/sciadv.aaw0109. eCollection 2019 Sep.

3.

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 E on blood stage immunity in young Kenyan children.

Ndungu FM, Mwacharo J, Wambua J, Njuguna P, Marsh K, Drakeley C, Bejon P.

Wellcome Open Res. 2019 Mar 5;4:42. doi: 10.12688/wellcomeopenres.15002.1. eCollection 2019.

4.

Repeated clinical malaria episodes are associated with modification of the immune system in children.

Bediako Y, Adams R, Reid AJ, Valletta JJ, Ndungu FM, Sodenkamp J, Mwacharo J, Ngoi JM, Kimani D, Kai O, Wambua J, Nyangweso G, de Villiers EP, Sanders M, Lotkowska ME, Lin JW, Manni S, Addy JWG, Recker M, Newbold C, Berriman M, Bejon P, Marsh K, Langhorne J.

BMC Med. 2019 Mar 13;17(1):60. doi: 10.1186/s12916-019-1292-y.

5.

Longitudinal Analysis of Infant Stool Bacteria Communities Before and After Acute Febrile Malaria and Artemether-Lumefantrine Treatment.

Mandal RK, Crane RJ, Berkley JA, Gumbi W, Wambua J, Ngoi JM, Ndungu FM, Schmidt NW.

J Infect Dis. 2019 Jul 19;220(4):687-698. doi: 10.1093/infdis/jiy740.

6.

Iron Status and Associated Malaria Risk Among African Children.

Muriuki JM, Mentzer AJ, Kimita W, Ndungu FM, Macharia AW, Webb EL, Lule SA, Morovat A, Hill AVS, Bejon P, Elliott AM, Williams TN, Atkinson SH.

Clin Infect Dis. 2019 May 17;68(11):1807-1814. doi: 10.1093/cid/ciy791.

7.

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.

Huttner A, Agnandji ST, Combescure C, Fernandes JF, Bache EB, Kabwende L, Ndungu FM, Brosnahan J, Monath TP, Lemaître B, Grillet S, Botto M, Engler O, Portmann J, Siegrist D, Bejon P, Silvera P, Kremsner P, Siegrist CA; VEBCON; VSV-EBOVAC; VSV-EBOPLUS Consortia.

Lancet Infect Dis. 2018 Jul;18(7):738-748. doi: 10.1016/S1473-3099(18)30165-8. Epub 2018 Apr 5.

8.

Public antibodies to malaria antigens generated by two LAIR1 insertion modalities.

Pieper K, Tan J, Piccoli L, Foglierini M, Barbieri S, Chen Y, Silacci-Fregni C, Wolf T, Jarrossay D, Anderle M, Abdi A, Ndungu FM, Doumbo OK, Traore B, Tran TM, Jongo S, Zenklusen I, Crompton PD, Daubenberger C, Bull PC, Sallusto F, Lanzavecchia A.

Nature. 2017 Aug 31;548(7669):597-601. doi: 10.1038/nature23670. Epub 2017 Aug 23.

9.

The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological "natural experiment".

Bediako Y, Ngoi JM, Nyangweso G, Wambua J, Opiyo M, Nduati EW, Bejon P, Marsh K, Ndungu FM.

BMC Med. 2016 Sep 22;14(1):143.

10.

Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models.

Ndungu FM, Marsh K, Fegan G, Wambua J, Nyangweso G, Ogada E, Mwangi T, Nyundo C, Macharia A, Uyoga S, Williams TN, Bejon P.

BMC Med. 2015 Aug 6;13:183. doi: 10.1186/s12916-015-0422-4.

11.

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

Olotu A, Clement F, Jongert E, Vekemans J, Njuguna P, Ndungu FM, Marsh K, Leroux-Roels G, Bejon P.

PLoS One. 2014 Dec 15;9(12):e115126. doi: 10.1371/journal.pone.0115126. eCollection 2014.

12.

Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers.

Ndungu FM, Lundblom K, Rono J, Illingworth J, Eriksson S, Färnert A.

Eur J Immunol. 2013 Nov;43(11):2919-29. doi: 10.1002/eji.201343630. Epub 2013 Aug 29.

13.

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.

Ibison F, Olotu A, Muema DM, Mwacharo J, Ohuma E, Kimani D, Marsh K, Bejon P, Ndungu FM.

PLoS One. 2012;7(12):e52939. doi: 10.1371/journal.pone.0052939. Epub 2012 Dec 26.

14.

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.

Ndungu FM, Mwacharo J, Kimani D, Kai O, Moris P, Jongert E, Vekemans J, Olotu A, Bejon P.

PLoS One. 2012;7(12):e52870. doi: 10.1371/journal.pone.0052870. Epub 2012 Dec 27.

15.

Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.

Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, Crompton PD, Marsh K, Ndungu FM.

J Immunol. 2013 Feb 1;190(3):1038-47. doi: 10.4049/jimmunol.1202438. Epub 2012 Dec 21.

16.

Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children.

Ndungu FM, Olotu A, Mwacharo J, Nyonda M, Apfeld J, Mramba LK, Fegan GW, Bejon P, Marsh K.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8247-52. doi: 10.1073/pnas.1200472109. Epub 2012 May 7.

17.

High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections.

Weiss GE, Ndungu FM, McKittrick N, Li S, Kimani D, Crompton PD, Marsh K, Pierce SK.

J Immunol Methods. 2012 Jan 31;375(1-2):68-74. doi: 10.1016/j.jim.2011.09.006. Epub 2011 Sep 22.

18.

Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study.

Muema DK, Ndungu FM, Kinyanjui SM, Berkley JA.

Malar J. 2011 Mar 5;10:55. doi: 10.1186/1475-2875-10-55.

19.

Distinct kinetics of memory B-cell and plasma-cell responses in peripheral blood following a blood-stage Plasmodium chabaudi infection in mice.

Nduati EW, Ng DH, Ndungu FM, Gardner P, Urban BC, Langhorne J.

PLoS One. 2010 Nov 23;5(11):e15007. doi: 10.1371/journal.pone.0015007.

20.

Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice.

Ndungu FM, Cadman ET, Coulcher J, Nduati E, Couper E, Macdonald DW, Ng D, Langhorne J.

PLoS Pathog. 2009 Dec;5(12):e1000690. doi: 10.1371/journal.ppat.1000690. Epub 2009 Dec 11.

21.

Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells.

Stephens R, Ndungu FM, Langhorne J.

Parasite Immunol. 2009 Jan;31(1):20-31. doi: 10.1111/j.1365-3024.2008.01066.x.

22.

Immunity to malaria: more questions than answers.

Langhorne J, Ndungu FM, Sponaas AM, Marsh K.

Nat Immunol. 2008 Jul;9(7):725-32. doi: 10.1038/ni.f.205. Review.

PMID:
18563083
23.
24.

Regulation of immune response by Plasmodium-infected red blood cells.

Ndungu FM, Urban BC, Marsh K, Langhorne J.

Parasite Immunol. 2005 Oct-Nov;27(10-11):373-84. Review.

25.

Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity.

Bull PC, Pain A, Ndungu FM, Kinyanjui SM, Roberts DJ, Newbold CI, Marsh K.

J Infect Dis. 2005 Sep 15;192(6):1119-26. Epub 2005 Aug 12. Erratum in: J Infect Dis. 2005 Nov 1;192(9):1678.

PMID:
16107968
26.

B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area.

Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, Lowe BS, Mwangi TW, Williams TN, Marsh K.

J Infect Dis. 2005 May 15;191(10):1623-30. Epub 2005 Apr 13.

PMID:
15838788

Supplemental Content

Loading ...
Support Center